California State Stem Cell Agency

REGULAR MEETING
GOVERNANCE SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: Wednesday, December 2, 2009
Time: 3:30- 5:00 PM

Locations:

CIRM
210 King Street
San Francisco, CA 94107

Klein Financial Corporation
550 California Avenue, Suite 330
Palo Alto, CA 94306

The Sherry Lansing Foundation
2121 Avenue of the Stars, Suite 2020
Los Angeles, CA 90067

Stanford University
Clark Center, Room S363
318 Campus Drive
Stanford CA, 94305

Reeve-Irvine Research Center
1105 Gillespie Neuroscience Research Facility (GNRF)
837 Health Science Road
University of California at Irvine School of Medicine
Irvine, CA 92697-4292

CONNECT
8950 Villa La Jolla Drive
Suite A-124
La Jolla, CA 92037

2476 Lancelot Lane
Los Angeles, CA 90077

Open Session

1. Call to Order.

2. Roll Call.

3. Consideration of agreement with Turner Consulting Group.

4. Consideration of agreement with 25by7 for network, server & desktop support.

5. Report on Grants Management System expenditures.

6. Update on contracts and interagency agreements.

7. Public Comment.

8. Adjournment.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov